1. Home
  2. RANI
  3. RANI News

Latest Rani Therapeutics Holdings Inc. (RANI) News on July 5, 2024

RANI: GLP-2 Deal Announced
RANI

Zacks Small Cap Research

7 days ago

RANI: GLP-2 Deal Announced

RANI

MT Newswires

11 days ago

Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
RANI

GlobeNewswire

11 days ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

RANI

MT Newswires

21 days ago

Maxim Starts Coverage on Rani Therapeutics With Buy Rating, $15 Price Target

RANI

MT Newswires

2 months ago

UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating

Rani Therapeutics to Participate in May Investor Conferences
RANI

GlobeNewswire

2 months ago

Rani Therapeutics to Participate in May Investor Conferences

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
RANI

GlobeNewswire

2 months ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

RANI: 1Q:24 Results
RANI

Zacks Small Cap Research

2 months ago

RANI: 1Q:24 Results

Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates
RANI

GuruFocus.com

2 months ago

Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

2 months ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock
RANI

Simply Wall St.

2 months ago

Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
RANI

Insider Monkey

3 months ago

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript

RANI: 2023 Results
RANI

Zacks Small Cap Research

3 months ago

RANI: 2023 Results

RANI

Thomson Reuters StreetEvents

3 months ago

Q4 2023 Rani Therapeutics Holdings Inc Earnings Call

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

3 months ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
RANI

GlobeNewswire

4 months ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company
RANI

Simply Wall St.

4 months ago

Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company

RANI: INITIATION – Realizing Oral Administration of Biologics
RANI

Zacks Small Cap Research

5 months ago

RANI: INITIATION – Realizing Oral Administration of Biologics

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)
RANI

GlobeNewswire

5 months ago

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics
RANI

Zacks

5 months ago

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics

Northrim BanCorp (NASDAQ:NRIM) Is Increasing Its Dividend To $0.61
RANI

Simply Wall St.

5 months ago

Northrim BanCorp (NASDAQ:NRIM) Is Increasing Its Dividend To $0.61

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share
RANI

GlobeNewswire

5 months ago

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
RANI

GlobeNewswire

5 months ago

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why
RANI

Zacks

5 months ago

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why

IX Acquisition Corp. Announces Tenth Extension of Deadline to Complete Initial Business Combination
RANI

GlobeNewswire

6 months ago

IX Acquisition Corp. Announces Tenth Extension of Deadline to Complete Initial Business Combination

DocGo Provides Additional Information to Refute Misleading Short Seller "Report"
RANI

Business Wire

6 months ago

DocGo Provides Additional Information to Refute Misleading Short Seller "Report"

Several Insiders Invested In Community West Bancshares Flagging Positive News
RANI

Simply Wall St.

6 months ago

Several Insiders Invested In Community West Bancshares Flagging Positive News

Senseonics Holdings, Inc. Announces Business Updates
RANI

Business Wire

6 months ago

Senseonics Holdings, Inc. Announces Business Updates

Next-Gen Riches: 3 Surprising Stock Picks to Boost Your $1,000 Investment
RANI

InvestorPlace

6 months ago

Next-Gen Riches: 3 Surprising Stock Picks to Boost Your $1,000 Investment

Farmers & Merchants Bancorp, Inc. and F&M Bank Announces the Appointment of Ian D. Boyce to its Board of Directors
RANI

GlobeNewswire

7 months ago

Farmers & Merchants Bancorp, Inc. and F&M Bank Announces the Appointment of Ian D. Boyce to its Board of Directors

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
RANI

GlobeNewswire

7 months ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

New Strong Buy Stocks for December 13th
RANI

Zacks

7 months ago

New Strong Buy Stocks for December 13th

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock
RANI

Zacks

7 months ago

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings
RANI

Simply Wall St.

7 months ago

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
RANI

Simply Wall St.

7 months ago

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock

Middlefield (MBCN) Stock Gains on Special Dividend Announcement
RANI

Zacks

8 months ago

Middlefield (MBCN) Stock Gains on Special Dividend Announcement

Independent Director of Eastern Picks Up 9.7% More Stock
RANI

Simply Wall St.

8 months ago

Independent Director of Eastern Picks Up 9.7% More Stock

RANI

GuruFocus.com

8 months ago

Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

8 months ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Share on Social Networks: